venetoclax和低甲基化药物治疗复发性BPDCN的前瞻性临床试验

Naveen Pemmaraju , Luan Hai Phan , Geoffrey Fell , Marlise R. Luskin , Mahesh Swaminathan , Sherry Pierce , Courtney DiNardo , Abhishek Maiti , Marina Konopleva , Andrew A. Lane
{"title":"venetoclax和低甲基化药物治疗复发性BPDCN的前瞻性临床试验","authors":"Naveen Pemmaraju , Luan Hai Phan , Geoffrey Fell , Marlise R. Luskin , Mahesh Swaminathan , Sherry Pierce , Courtney DiNardo , Abhishek Maiti , Marina Konopleva , Andrew A. Lane","doi":"10.1016/j.bneo.2025.100086","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100189,"journal":{"name":"Blood Neoplasia","volume":"2 2","pages":"Article 100086"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN\",\"authors\":\"Naveen Pemmaraju , Luan Hai Phan , Geoffrey Fell , Marlise R. Luskin , Mahesh Swaminathan , Sherry Pierce , Courtney DiNardo , Abhishek Maiti , Marina Konopleva , Andrew A. Lane\",\"doi\":\"10.1016/j.bneo.2025.100086\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100189,\"journal\":{\"name\":\"Blood Neoplasia\",\"volume\":\"2 2\",\"pages\":\"Article 100086\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Neoplasia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950328025000214\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Neoplasia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950328025000214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信